Navigation Links
New head-to-head clinical studies reveal Reach Ultraclean toothbrush and floss deliver superior plaque removal compared to leading competitive products
Date:4/6/2009

MORRIS PLAINS, N.J., April 6, 2009 New head-to-head clinical trial results demonstrate that REACH ULTRACLEAN Toothbrush and Floss deliver superior plaque removal. The five studies conducted by Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc., and presented today during the 87th General Session and Exhibition of the International Association for Dental Research in Miami collectively found:

  • REACH ULTRACLEAN Floss removes up to two times more plaque than Glide* floss products. i
  • REACH ULTRACLEAN Toothbrush removes more plaque and provides improved gum health versus the Colgate 360** toothbrush. The REACH ULTRACLEAN Toothbrush also removes up to 90 percent of plaque in places that are hard to reach.ii

"The results of the clinical trials for the REACH ULTRACLEAN Toothbrush and Floss help set a new standard for the oral care tools patients use in the fight against plaque," said Sylvia Santos, RDH, MS, Associate Director, R&D, Johnson & Johnson Consumer & Personal Products Worldwide, Division of Johnson & Johnson Consumer Companies, Inc. "Through innovative design and unmatched cleaning technology, we continue to help patients achieve cleaner, healthier mouths."

About the Clinical Studies

Four randomized, observer-blind, three-way crossover and controlled studies were conducted for the REACH ULTRACLEAN Floss to determine dental plaque removal efficacy by flossing. The results demonstrate that REACH ULTRACLEAN Floss removes up to two times more interproximal plaque than Crest Glide Original Mint, Crest Glide Deep Clean, Crest Glide Whitening Plus Scope, Crest Glide Comfort Plus and Crest Glide Shred Guard. Subjects received a pre-flossing plaque examinationiii by a trained dental examiner and were randomly assigned to a sequence of treatments. Surrogate flossing was performed by a trained dental hygienist and post-flossing plaque assessments were conducted by the trained dental examiner. Subjects made three visits to the site with at least 24 hours of rest between each visit.

The fifth study, which examined the REACH ULTRACLEAN Toothbrush, was a 30-day observer-blind, parallel and controlled clinical study. It was conducted to determine dental plaque removal efficacy by brushing. Results show that the REACH ULTRACLEAN Toothbrush removes up to 90 percent of plaque in places that are hard to reach. The toothbrush also removes more plaque and provides improved gum health compared to Colgate 360 following 30 days of use. Subjects received assessments for safety, gingivitisiv and pre-brushing plaque levels on all teeth.v Subjects brushed in their usual manner for two minutes twice daily with their randomly assigned toothbrush and fluoride toothpaste. Subjects received pre- and post-brushing examinations for oral soft tissue assessment, gingivitis and plaque levels on Days 1 and 30.

About the Products

The REACH ULTRACLEAN Floss contains MICRO-GROOVES technology that flex to adapt to the contours between the teeth to provide superior cleaning. The exclusive MICRO-GROOVES technology slide easily to grab and remove plaque. The end result the unique, stretchy, no-shred dental floss offers a comfortable cleaning experience that is gentle on the gums.

The REACH ULTRACLEAN Toothbrush offers the signature REACH angled neck designed like a dental instrument to clean places that are hard to reach. Multi-level bristles and a dense cleansing tip together thoroughly clean between teeth, behind teeth and along the gum lines. The toothbrush also features an ergonomic handle with a thumb grip for greater control and comfort.


'/>"/>

Contact: Allison Goldstein
allison.goldstein@edelman.com
212-704-4511
Edelman Public Relations
Source:Eurekalert

Related medicine news :

1. Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study
2. Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel
3. In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack
4. Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients
5. Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Clinical depression linked to abnormal emotional brain circuits
8. Preclinical study suggests organ-transplant drug may aid in lupus fight
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Good Clinical Practice Journal Awards: Winners Announced
11. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 Story Highlights: ... within the health care industry is causing providers to ... , Deloitte offers a suite of solutions for health ... efficient cost optimization: labor resource analysis, revenue cycle optimization ... better outcomes and better economics ...
(Date:6/24/2016)... , June 24, 2016   Bay ... Rehabilitation Network,s Dean Center for Tick Borne ... Medicine and Rehabilitation, MIT Hacking Medicine, University of ... Innovation, today announced the five finalists of ... Lyme disease.  More than 100 scientists, clinicians, researchers, ...
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
Breaking Medicine Technology: